# Baxter Healthcare expands IV fluid manufacturing in Australia with $40M investment

The Australian government and Baxter Healthcare each invest $20 million to expand Baxter's onshore IV fluid manufacturing capacity in Old Toongabbie, Western Sydney, increasing annual production by at least 20 million units to 80 million units by 2027.

- Type: Expansion
- Announced: 2025-03-05
- Where: Old Toongabbie, Western Sydney, Australia
- Value: $25.0M (40.0M AUD)
- Starts operating: 2027
- Status: announced
- Capacity: 80 million units annually by 2027
- Products: intravenous (IV) fluids
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Baxter Healthcare](https://endata.com/companies/34157.md)
- [Australian Government](https://endata.com/companies/19968.md) (investor)

## Sources

- [healthindustryhub.com.au](https://www.healthindustryhub.com.au/medical-technology-news-trends/baxter-partners-with-labor-government-in-expanding-sovereign-supply-of-iv-fluids/), 2025-03-05: "Our investment will now cover IV demand for Australia and we will no longer be hostage to overseas supply."
- [baxterhealthcare.com.au](https://www.baxterhealthcare.com.au/baxter-newsroom/baxter-healthcare-and-australian-government-announce-40-million-investment-towards), 2025-03-05: "This is an extraordinary investment in IV fluid production."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.